Ocrevus - Are most insurance carriers approving this medicine ?
Question posted by Anitapdm on 29 March 2017
Last updated on 18 March 2020 by streetstock14
I want to know if medicare and blue cross covers this for people over 65
The FDA has approved Ocrevus (ocrelizumab) for the treatment of adults with primary progressive MS and with relapsing MS.
List cost is $65,000 per year so access will depend on individual insurance plans.
For people who qualify, Genentech plans to offer patient assistance programs through Genentech Access Solutions: (866) 4ACCESS/(866) 422-2377 or http://www.Genentech-Access.com.
- Ocrevus uses and safety info
- Ocrevus information for Healthcare Professionals (includes dosage details)
- Side effects of Ocrevus (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.